AlloVir Market Cap

AlloVir has a market cap or net worth of $89.70 million as of May 17, 2024. Its market cap has decreased by -77.18% in one year.

Market Cap

89.70M

Enterprise Value

-33.04M

1-Year Change

-77.18%

Ranking

#4203

Market Cap Chart

Since July 30, 2020, AlloVir's market cap has decreased from $1.55B to $89.70M, a decrease of -94.22%. That is a compound annual growth rate of -52.78%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	89.10M	3.13%
May 16, 2024	86.40M	0.12%
May 15, 2024	86.30M	-2.82%
May 14, 2024	88.80M	2.90%
May 13, 2024	86.30M	-4.32%
May 10, 2024	90.20M	-3.74%
May 9, 2024	93.70M	4.34%
May 8, 2024	89.80M	-1.75%
May 7, 2024	91.40M	-1.30%
May 6, 2024	92.60M	0.98%
May 3, 2024	91.70M	-0.97%
May 2, 2024	92.60M	-0.43%
May 1, 2024	93.00M	1.97%
Apr 30, 2024	91.20M	-2.56%
Apr 29, 2024	93.60M	2.18%
Apr 26, 2024	91.60M	-0.33%
Apr 25, 2024	91.90M	2.57%
Apr 24, 2024	89.60M	-1.43%
Apr 23, 2024	90.90M	3.77%
Apr 22, 2024	87.60M	1.62%
Apr 19, 2024	86.20M	1.17%
Apr 18, 2024	85.20M	-2.07%
Apr 17, 2024	87.00M	3.08%
Apr 16, 2024	84.40M	-1.52%
Apr 15, 2024	85.70M	-2.72%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Barinthus Biotherapeutics	88.43M
SHL Telemedicine	88.19M
Spero Therapeutics	88.06M
SELLAS Life Sciences Group	87.79M
Chimerix	87.39M
Allurion Technologies	86.97M
Oncolytics Biotech	85.98M
Passage Bio	84.41M

Market Cap Rankings